IOANNIS KOUTELIDAKIS

Prof. IOANNIS KOUTELIDAKIS


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
TAT.E.F. Abbott
T.E.F. Abbott
AFA.J. Fowler
A.J. Fowler
MCM.S. Chew
M.S. Chew
RPRupert M. Pearse
Rupert M. Pearse
SBScott Beattie
Scott Beattie
TWTroy Wildes
Troy Wildes

1 February 2017 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
EGEvangelos J Giamarellos-Bourboulis
Evangelos J Giamarellos-Bourboulis
TTT. Tsaganos
T. Tsaganos
ITI. Tsangaris
I. Tsangaris
MLM. Lada
M. Lada
CRC. Routsi
C. Routsi
CGC. Gogos
C. Gogos

26 May 2010 in Critical Care
Verified
Journal Article
Open access
PDF file
CGCharalambos Gogos
Charalambos Gogos
AKAntigoni Kotsaki
Antigoni Kotsaki
APAimilia Pelekanou
Aimilia Pelekanou
GGGeorge Giannikopoulos
George Giannikopoulos
IVIlia Vaki
Ilia Vaki
EGEvangelos J Giamarellos-Bourboulis
Evangelos J Giamarellos-Bourboulis
Introduction: Although major changes of the immune system have been described in sepsis, it has never been studied whether these may differ in relation to the type of underlying infection or not. This was studied for the first time. Methods: The statuses of the innate and adaptive immune systems were prospectively compared in 505 patients. Whole blood was sampled within less than 24 hours of advent of sepsis; white blood cells were stained with monoclonal antibodies and analyzed though a flow cytometer. Results: Expression of HLA-DR was significantly decreased among patients with severe sepsis/shock due to acute pyelonephritis and intraabdominal infections compared with sepsis. The rate of apoptosis of natural killer (NK) cells differed significantly among patients with severe sepsis/shock due to ventilator-associated pneumonia (VAP) and hospital-acquired pneumonia (HAP) compared with sepsis. The rate of apoptosis of NKT cells differed significantly among patients with severe sepsis/shock due to acute pyelonephritis, primary bacteremia and VAP/HAP compared with sepsis. Regarding adaptive immunity, absolute counts of CD4-lymphocytes were significantly decreased among patients with severe sepsis/shock due to community-acquired pneumonia (CAP) and intraabdominal infections compared with sepsis. Absolute counts of B-lymphocytes were significantly decreased among patients with severe sepsis/shock due to CAP compared with sepsis. Conclusions: Major differences of the early statuses of the innate and adaptive immune systems exist between sepsis and severe sepsis/shock in relation to the underlying type of infection. These results may have a major impact on therapeutics.

8 August 2012 in Critical Care
Verified
Journal Article
Open access
PDF file
EGEvangelos J Giamarellos-Bourboulis
Evangelos J Giamarellos-Bourboulis
ATAnna Norrby Teglund
Anna Norrby Teglund
VMVassiliki Mylona
Vassiliki Mylona
ASAthina Savva
Athina Savva
Iraklis TsangarisIraklis Tsangaris
Iraklis Tsangaris
George DimopoulosGeorge Dimopoulos
George Dimopoulos
Introduction: Early risk assessment is the mainstay of management of patients with sepsis. APACHE II is the gold standard prognostic stratification system. A prediction rule that aimed to improve prognostication by APACHE II with the application of serum suPAR (soluble urokinase plasminogen activator receptor) is developed. Methods: A prospective study cohort enrolled 1914 patients with sepsis including 62.2% with sepsis and 37.8% with severe sepsis/septic shock. Serum suPAR was measured in samples drawn after diagnosis by an enzyme-immunoabsorbent assay; in 367 patients sequential measurements were performed. After ROC analysis and multivariate logistic regression analysis a prediction rule for risk was developed. The rule was validated in a double-blind fashion by an independent confirmation cohort of 196 sepsis patients, predominantly severe sepsis/septic shock patients, from Sweden. Results: Serum suPAR remained stable within survivors and non-survivors for 10 days. Regression analysis showed that APACHE II ≥17 and suPAR ≥12 ng/ml were independently associated with unfavorable outcome. Four strata of risk were identified: i) APACHE II <17 and suPAR <12 ng/ml with mortality 5.5%; ii) APACHE II < 17 and suPAR ≥12 ng/ml with mortality 17.4%; iii) APACHE II ≥ 17 and suPAR <12 ng/ml with mortality 37.4%; and iv) APACHE II ≥17 and suPAR ≥12 ng/ml with mortality 51.7%. This prediction rule was confirmed by the Swedish cohort. Conclusions: A novel prediction rule with four levels of risk in sepsis based on APACHE II score and serum suPAR is proposed. Prognostication by this rule is confirmed by an independent cohort.

28 August 2001 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
TPT. Pavlidis
T. Pavlidis
BPB. Papaziogas
B. Papaziogas
ASA. Souparis
A. Souparis
APA. Patsas
A. Patsas
IKIOANNIS KOUTELIDAKIS
IOANNIS KOUTELIDAKIS
TPT. Papaziogas
T. Papaziogas

29 May 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
DSDimitrios Sinapidis
Dimitrios Sinapidis
VKVassileios Kosmas
Vassileios Kosmas
VVVasileios Vittoros
Vasileios Vittoros
IKIOANNIS KOUTELIDAKIS
IOANNIS KOUTELIDAKIS
APAikaterini Pantazi
Aikaterini Pantazi
EGEvangelos J Giamarellos-Bourboulis
Evangelos J Giamarellos-Bourboulis
Development of sepsis is a process with significant variation among individuals. The precise elements of this variation need to be defined. This study was designed to define the way in which comorbidities contribute to sepsis development. Three thousand five hundred nine patients with acute pyelonephritis (AP), community-acquired pneumonia (CAP), intraabdominal infections (IAI) or primary bacteremia (BSI) and at least two signs of the systemic inflammatory response syndrome were analyzed. The study primary endpoint was to define how comorbidities as expressed in the Charlson’s comorbidity index (CCI) and the underlying type of infection contribute to development of organ dysfunction. The precise comorbidities that mediate sepsis development and risk for death among 18 comorbidities recorded were the secondary study endpoints. CCI more than 2 had an odds ratio of 5.67 for sepsis progression in patients with IAI between significantly higher than AP and BSI. Forward logistic regression analysis indicated seven comorbidities that determine transition into sepsis in patients with AP, four comorbidities in CAP, six comorbidities in IAI and one in BSI. The odds ratio both for progression to sepsis and death with one comorbidity or with two and more comorbidities was greater than in the absence of comorbidities. The study described how different kinds of infection vary in the degree to which they lead to sepsis. The number of comorbidities that enhances the risk of sepsis and death varies depending on the underlying infections.